Pharmaceutical formulation comprising ciclesonide

US10925964B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10925964-B2
Application numberUS-201314132578-A
CountryUS
Kind codeB2
Filing dateDec 18, 2013
Priority dateDec 21, 2012
Publication dateFeb 23, 2021
Grant dateFeb 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A pharmaceutical formulation consisting of ciclesonide, hydrochloric acid, water and ethanol, wherein said formulation has a −log 10 [H+] of 4.5, and said formulation includes the following amounts of: concentration Ingredient [in 100 mL] Ciclesonide 3.0 g HCl (0.1 M) 0.0424 mL Ethanol (100% v/v 68.8 g ethanol/water) Water 11.5 g. 2. An inhalation kit comprising a pharmaceutical formulation according to claim 1 , an inhaler device and an instruction leaflet comprising instructions and directions for use. 3. The inhalation kit according to claim 2 , wherein said inhaler device nebulizes said pharmaceutical formulation. 4. The inhalation kit according to claim 2 , where said inhaler device is a pressurized metered dose inhaler. 5. The inhalation kit according to claim 2 , wherein said inhaler device is a non-pressurized metered dose aqueous/ethanolic droplet inhaler. 6. The inhalation kit according to claim 2 , wherein said inhaler device comprises an adapter for equine use.

Assignees

Inventors

Classifications

  • A61K31/58Primary

    containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048}) · CPC title

  • Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M) · CPC title

  • Drugs for disorders of the respiratory system · CPC title

  • Solutions {(composition of solutions A61K47/00)} · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10925964B2 cover?
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
Who is the assignee on this patent?
Aven Michael, Albrecht Balazs, Franzmann Benjamin, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61K31/58. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).